Recursion Bridges The Protein And Chemical Space With Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds
Portfolio Pulse from Happy Mohamed
Recursion (NASDAQ:RXRX) has successfully screened the Enamine REAL Space chemical library using its MatchMaker technology, recently acquired from Cyclica, to predict the protein target(s) for approximately 36 billion chemical compounds. The company generated this massive new data layer of predicted interactions in less than 90 days after closing the acquisition of Cyclica and in under 30 days since initiating the collaboration with NVIDIA. Recursion plans to leverage this new database of predictions to industrialize its chemistry operations across its pipeline and in service to its partners.
August 08, 2023 | 12:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Recursion's successful screening of the Enamine REAL Space chemical library using its MatchMaker technology could potentially accelerate its drug discovery process. This could lead to increased efficiency in its medicinal chemistry cycles and potentially enhance its market position.
The successful screening of the Enamine REAL Space chemical library using MatchMaker technology represents a significant advancement in Recursion's drug discovery process. This could potentially lead to the discovery of new drug targets, accelerating the company's drug development pipeline and potentially enhancing its market position.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100